Biologics Quality Control Testing
PathoQuest, a spin-out of Institut Pasteur Paris, is a genomics expert company offering a game-changing next-generation sequencing (NGS) approach for microbiology testing.
The NGS-based technology the company has developed is used for:
• The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GMP level
PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.
PathoQuest Appoints Dr. Klaus Binder to Company’s Board of Directors
News ReleasePathoQuest, the leading expert in...
Oxford Nanopore and PathoQuest announce next step of strategic collaboration to bring to market the first sequencing-based quality control test for biopharma genetic characterisation
Press ReleaseNanopore sequencing combined with...
PathoQuest Webinar (Archived): It’s Better to Know Now vs. Later: Genetic Characterisation of Gene Therapy Vectors & Vaccines by NGS
This webinar reviews considerations for genetic characterization testing of gene therapy vectors and vaccines focusing on the advantages NGS offers over Sanger sequencing and other classical methods like restriction analysis or PCR testing.
Let’s Start Something New
Welcome to PathoQuest!